Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 5,6-EET | cPLA2i | 1.0 | BCD110605C16 | 2.43 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 1.0 | BCD110605C18 | 2.02 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 1.0 | BCD110605C17 | 2.32 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 4.0 | BCD110605C34 | 2.34 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 4.0 | BCD110605C36 | 2.57 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 4.0 | BCD110605C35 | 2.66 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 20.0 | BCD110605C53 | 0.837 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 20.0 | BCD110605C54 | 0.933 | pmol/ml of medium |
| - | 5,6-EET | cPLA2i | 20.0 | BCD110605C52 | 1.11 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 1.0 | BCD110605C10 | 2.16 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 1.0 | BCD110605C12 | 2.15 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 1.0 | BCD110605C11 | 2.65 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 4.0 | BCD110605C30 | 2.42 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 4.0 | BCD110605C29 | 2.42 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 4.0 | BCD110605C28 | 2.48 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 20.0 | BCD110605C48 | 0.926 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 20.0 | BCD110605C47 | 1.11 | pmol/ml of medium |
| - | 5,6-EET | PLDi | 20.0 | BCD110605C46 | 1.09 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 1.0 | BCD110605C19 | 2.78 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 1.0 | BCD110605C21 | 2.62 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 1.0 | BCD110605C20 | 2.51 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 4.0 | BCD110605C39 | 6.3 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 4.0 | BCD110605C37 | 5.71 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 4.0 | BCD110605C38 | 6.1 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 20.0 | BCD110605C55 | 4.33 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 20.0 | BCD110605C57 | 4.29 | pmol/ml of medium |
| - | 5,6-EET | KDO+cPLA2i | 20.0 | BCD110605C56 | 4.93 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 1.0 | BCD110605C15 | 2.96 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 1.0 | BCD110605C14 | 2.84 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 1.0 | BCD110605C13 | 2.48 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 4.0 | BCD110605C32 | 5.87 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 4.0 | BCD110605C31 | 7.3 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 4.0 | BCD110605C33 | 6.74 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 20.0 | BCD110605C49 | 5.9 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 20.0 | BCD110605C51 | 6.69 | pmol/ml of medium |
| - | 5,6-EET | KDO+PLDi | 20.0 | BCD110605C50 | 6.49 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 1.0 | BCD110605C07 | 2.54 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 1.0 | BCD110605C09 | 2.95 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 1.0 | BCD110605C08 | 2.93 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 4.0 | BCD110605C25 | 7.88 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 4.0 | BCD110605C26 | 6.6 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 4.0 | BCD110605C27 | 6.95 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 20.0 | BCD110605C45 | 6.1 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 20.0 | BCD110605C43 | 4.11 | pmol/ml of medium |
| - | 5,6-EET | KDO + ATP | 20.0 | BCD110605C44 | 6.83 | pmol/ml of medium |
| - | 5,6-EET | C | 0.0 | BCD110605C02 | 1.72 | pmol/ml of medium |
| - | 5,6-EET | C | 0.0 | BCD110605C01 | 1.91 | pmol/ml of medium |
| - | 5,6-EET | C | 0.0 | BCD110605C03 | 2.04 | pmol/ml of medium |
| - | 5,6-EET | C | 1.0 | BCD110605C06 | 1.99 | pmol/ml of medium |
| - | 5,6-EET | C | 1.0 | BCD110605C05 | 2.16 | pmol/ml of medium |